BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.62B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 3 |
iShares Biotechnology ETF
IBB
|
+$563M |
| 4 |
Bank of America
BAC
|
+$478M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$156M |
| 2 |
AT&T
T
|
+$148M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$126M |
| 4 |
Verizon
VZ
|
+$117M |
| 5 |
Johnson & Johnson
JNJ
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.07% |
| 2 | Financials | 8.49% |
| 3 | Consumer Discretionary | 6.41% |
| 4 | Industrials | 6.25% |
| 5 | Healthcare | 5.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Nordson
NDSN
$17.3B
| $137K | ﹤0.01% |
1,753
+532
| +44% | +$40.3K |
|
|
WOOF
1577
DELISTED
VCA Inc.
WOOF
| $137K | ﹤0.01% |
2,494
+674
| +37% | +$35.2K |
|
1578
Charles River Laboratories
CRL
$13.4B
| $136K | ﹤0.01% |
1,716
+733
| +75% | +$54.1K |
|
1579
Autoliv
ALV
$8.89B
| $136K | ﹤0.01% |
1,602
+339
| +27% | +$26.9K |
|
|
MIE
1580
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
| $134K | ﹤0.01% |
+7,139
| New | +$138K |
|
1581
Moog Inc Class A
MOG.A
$13.5B
| $133K | ﹤0.01% |
1,776
+1,147
| +182% | +$84.8K |
|
|
CLNY
1582
DELISTED
Colony Capital, Inc.
CLNY
| $132K | ﹤0.01% |
5,104
+1,571
| +44% | +$39.4K |
|
1583
STAG Industrial
STAG
$7.12B
| $131K | ﹤0.01% |
+5,590
| New | +$141K |
|
1584
Mercury Insurance
MCY
$5.81B
| $131K | ﹤0.01% |
2,274
+287
| +14% | +$16.1K |
|
|
MZOR
1585
DELISTED
Mazor Robotics Ltd.
MZOR
| $131K | ﹤0.01% |
11,642
| – | – |
|
|
EE
1586
DELISTED
El Paso Electric Company
EE
| $131K | ﹤0.01% |
+3,383
| New | +$130K |
|
|
CPHD
1587
DELISTED
Cepheid Inc
CPHD
| $131K | ﹤0.01% |
2,296
+1,713
| +294% | +$96.3K |
|
1588
Puma Biotechnology
PBYI
$450M
| $130K | ﹤0.01% |
+552
| New | +$118K |
|
|
LNCO
1589
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
| $130K | ﹤0.01% |
13,559
+1,283
| +10% | +$13.8K |
|
1590
Copart
CPRT
$27.2B
| $130K | ﹤0.01% |
27,600
+9,048
| +49% | +$41.9K |
|
1591
Graco
GGG
$13.3B
| $129K | ﹤0.01% |
5,373
+1,629
| +44% | +$40.6K |
|
1592
Arrowhead Research
ARWR
$12.1B
| $127K | ﹤0.01% |
18,778
-1,222
| -6% | -$8.67K |
|
1593
Flowers Foods
FLO
$1.6B
| $127K | ﹤0.01% |
5,582
+1,815
| +48% | +$37.7K |
|
1594
Applied Industrial Technologies
AIT
$13.2B
| $127K | ﹤0.01% |
2,794
+2,237
| +402% | +$95.6K |
|
|
PDCE
1595
DELISTED
PDC Energy, Inc.
PDCE
| $126K | ﹤0.01% |
2,340
-1,850
| -44% | -$89.6K |
|
|
ACG
1596
DELISTED
AllianceBernstein Income Fund Inc
ACG
| $126K | ﹤0.01% |
16,350
-3,800
| -19% | -$28.6K |
|
|
AEGN
1597
DELISTED
Aegion Corp
AEGN
| $126K | ﹤0.01% |
6,988
+4,069
| +139% | +$69.6K |
|
1598
Prothena Corp
PRTA
$466M
| $126K | ﹤0.01% |
3,303
+631
| +24% | +$16.2K |
|
|
LTM
1599
DELISTED
LIFE TIME FITNESS INC
LTM
| $126K | ﹤0.01% |
+1,769
| New | +$106K |
|
|
ACHN
1600
DELISTED
Achillion Pharmaceuticals
ACHN
| $125K | ﹤0.01% |
12,692
+7,692
| +154% | +$96K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2015 Portfolio in Review
As of Q1 2015, BNP Paribas Financial Markets held 3,714 positions worth $36.1B, up 28% from $28.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
BNP Paribas Financial Markets deployed $6.48B of net new capital in Q1 2015, opening 1,715 new positions and adding to 1,001 existing holdings. Its largest new stake was State Street SPDR S&P Retail ETF: 3,604,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Potash Corp Of Saskatchewan, an estimated $156M trimmed.
- BNP Paribas Financial Markets's largest Q1 2015 buy was State Street SPDR S&P Retail ETF: 3,604,020 shares worth $182M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q1 2015, an estimated $1.62B increase.
- BNP Paribas Financial Markets's biggest Q1 2015 reduction was Potash Corp Of Saskatchewan, cutting an estimated $156M.
- BNP Paribas Financial Markets fully exited Allergan Inc in Q1 2015, selling an estimated $98.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 39% of its $36.1B portfolio in Q1 2015.
- BNP Paribas Financial Markets opened 1,715 new positions and closed 104 in Q1 2015.
- BNP Paribas Financial Markets's portfolio value rose 28% quarter-over-quarter to $36.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2015, filed 15 May 2015.